Related Experiment Video
Updated: Jul 12, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Dystonia during feeding as an early sign of dopa-responsive dystonia
Kwong S Chieng1, Nahin Hussain, Jayaprakash A Gosalakkal
1Department of Paediatric Neurology, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, United Kingdom. ChiengSiikKwong@hotmail.com
Insights
Levodopa therapy dramatically improved a young girl with severe feeding difficulties, dystonia, and developmental delay. This treatment resolved her symptoms and facilitated significant developmental catch-up, highlighting its therapeutic potential.
Area of Science:
- Pediatric Neurology
- Neurodevelopmental Disorders
Background:
- A 2.5-month-old infant presented with severe feeding difficulties including crying, vomiting, arching, and rigidity.
- Initial suspicion of gastroesophageal reflux disease (GERD) was noted, but dystonia and developmental delay emerged by 8 months.
Observation:
- The infant underwent nasogastric tube feeding and Nissen's fundoplication, and received treatments like baclofen and trihexyphenidyl without improvement.
- Marked head lag, dystonia, and rigidity characterized her severe developmental delay.
Findings:
- Initiation of Levodopa therapy at 21 months led to a dramatic and rapid improvement in symptoms.
- Dystonia, rigidity, and retching resolved shortly after starting Levodopa, with significant developmental catch-up observed.
Implications:
- Levodopa therapy demonstrated remarkable efficacy in treating severe infantile-onset dystonia and developmental delay.
- This case underscores the importance of considering treatable neurometabolic or neurodegenerative disorders presenting with severe motor and developmental impairments.
Abstract:
A 21/2-month-old girl presented with feeding difficulties of 8 weeks' duration. She cried, vomited, arched, and became rigid during every feeding. She was suspected of having gastroesophageal reflux disease. Dystonia and developmental delay became apparent at age 8 months. Nasogastric tube feeding and gastrostomy with Nissen's fundoplication were performed at age 7 and 12 months, respectively. She was treated with baclofen, trihexyphenidyl, and antireflux therapy, without benefit. She became severely developmentally delayed with marked head lag, dystonia, and rigidity. Levodopa therapy was initiated at age 21 months. She manifested dramatic improvement over the next year. Dystonia, rigidity, and retching disappeared soon after treatment. She experienced good catch-up in development. She exhibited poor head control and an inability to reach out at age 21 months, but bottom shuffling was observed at age 26 months, and walking and speaking three-word sentences at age 2 years and 10 months. Pertinent issues relating to signs, pathophysiology, genetics, and biochemical defects are discussed briefly.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Alterations in Muscle Tone ll
Pyloric Obstruction
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll